© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Tylvalosin Tartrate stands as a semi-synthetic macrolide antibiotic, developed from tylosin through targeted chemical modification. Producers prefer this compound to tackle specific bacterial infections in swine and poultry, where resistance concerns continue to mount against more established antibiotics. As a tartrate salt form, its molecular formula presents as C47H80N2O18·C4H6O6, reflecting both the antibiotic backbone and the tartrate stabilizer. Each crystal carries a distinct pale off-white to slight yellow coloring, with smooth flake or powder textures. Farmers value its predictable solubility, which simplifies oral administration via drinking water, a route that avoids feed mill complexity and ensures more consistent delivery per animal.
The raw material form impresses with well-defined solid flake or crystalline powder, carrying a density in the range of 1.2–1.3 g/cm³. Handling reveals a faint odor, but little airborne dust if managed at standard humidity, lowering the risk of respiratory exposure in typical agricultural settings. The material dissolves efficiently in water, supporting a quick-mixing solution that resists clumping. As with other veterinary pharmaceuticals, it stays stable in ambient storage as a protected solid, but will degrade if exposed to strong acids, alkalis, or prolonged sunlight.
Scientists engineered Tylvalosin Tartrate to feature a 16-membered lactone ring, a key feature in the macrolide antibiotic group. This ring interacts with the tartrate moiety, boosting solubility and bioavailability. Its molecular mass falls close to 1082 grams per mole, and the chemical architecture favors targeting Gram-positive bacteria, especially respiratory and enteric pathogens.
The product lands under Harmonized System (HS) Code 2941.90, which sorts macrolide antibiotics for regulatory and customs purposes. Purity specifications often read above 98% on a dry basis, and the standard packaging comes in moisture-resistant drums, lined with polyethylene for chemical safety. Quality-minded buyers expect lot analysis to feature loss on drying measurements below 2%, and residue on ignition under 0.5%, confirming a lack of inorganic contamination.
Responsible use demands clear attention to safety. Tylvalosin Tartrate counts as hazardous if mishandled; inhalation or skin contact may cause allergic reactions in sensitive handlers. Material Safety Data Sheets recommend gloves, goggles, and dust masks during bulk handling. Spills, though rare, require wet-doweling rather than dry-sweeping, since the compound partly dissolves in trace moisture. Disposal routes privilege chemical incineration over landfill to limit antibiotic accumulation in local ecologies, as agricultural run-off has become a growing global concern for antimicrobial resistance. Literature links environmental release to a rising risk of resistance genes transferring into wild species, intensifying the push for closed-loop waste protocols among modern farm operators.
Farms where I’ve seen Tylvalosin Tartrate put to work generally follow vigorous batch tracking, product rotation, and mixing controls to ensure dosage consistency. Mistakes around dosing rarely come from the supplier’s end; rather, problems surface when solutions sit out too long, or when ambient humidity spoils unsealed raw material. The most skilled managers store containers in locked, climate-moderated rooms, track logbooks by lot number, and keep emergency spill kits nearby. Factory audits often dig into cleaning protocols, training frequency, and separation from human pharmaceuticals, recognizing that veterinary active ingredients demand the same respect for human safety as any mainstream medication.
Efforts to substitute Tylvalosin Tartrate with lower-risk molecules have met stiff headwinds, mostly because this compound hits a broad pathogen spectrum without causing the side effects of earlier-generation macrolides. The chemical’s very success brings hard choices about stewardship. Producers and veterinary groups balance the gains in animal health against the rising tide of resistance—dictating careful prescription tracking, batch-level identification, and withdrawal period documentation. Countries with strong residue testing programs keep noncompliant product out of the food chain, but gaps in global enforcement mean vigilant self-regulation matters as much as any national guideline.
Moving ahead, I see more farmers and feed engineers shifting toward water-soluble product measured with precision scales and digital dosing pumps. Automated tracking reconciles actual use against prescriptions, triggering faster intervention if something falls out of specification. Agricultural universities and pharma suppliers should prioritize clear labeling, signal-word safety labeling, and training kits for operators, not just for compliance but to cut back on accidental environmental releases. Ongoing collaboration with regulatory agencies, livestock veterinarians, and supply-chain experts will help ensure Tylvalosin Tartrate keeps serving animal health needs, while minimizing risks to workers, consumers, and the environment.
